Wednesday, May 3, 2017
Thursday, May 4, 2017
Friday, May 5, 2017
Saturday, May 6, 2017
| Time | Banquet Hall | N. Skalkotas Hall | MC2 |
| 13:00-14:30 | Symposium 1 Melanoma: New Developments – open questions Chairs: C. Garbe (Germany) - C. Hoeller (Austria) C. Hoeller (Austria): PD-1 and CTLA-4: Upfront or sequentially?
D. Schadendorf (Germany): How long checkpoint inhibition – Until objective response? G. Long (Australia): Choice of immunotherapy versus targeted therapy in first line treatment for BRAF-mutant melanoma V. Kinsler (United Kingdom): Melanoma arising from congenital nevi: New developments in treatment P. Lorigan (UK): Update on mucosal and uveal Melanoma |
Dermoscopy Course I Chairs: I. Zalaudek (Austria) – A. Lallas (Greece) In collaboration with the International Society of Dermoscopy I. Zalaudek (Austria): Dermoscopy and the evolution of melanocytic nevi
J. Malvehy (Spain): Dermoscopic overview of melanoma C. Longo (Italy): Benign non-melanocytic lesions A. Lallas (Greece): The morphologic universe of basal cell carcinoma D. Sgouros (Greece): The spectrum of keratinocyte skin cancer |
|
| 14:30-15:30 | Industry Satellite Lecture 1 14:30-15:00 Click here for more information |
Industry Satellite Symposium 1 Click here for more information |
|
| 15:30-16:00 | Coffee Break & ePosters viewing |
||
| 16:00-17:30 | Symposium 2 Melanoma and NMSC: New Developments – open questions Chairs: J.J. Grob (France) - H. Pehamberger (Austria) A. Hauschild (Germany): Targeted therapy in NRAS-mutated melanoma
Β. Dreno (France): Vaccines and adoptive T-cell transfer C. Lebbe (France): Immunotherapy in Merkel cell carcinoma R. Gutzmer (Germany): Targeted therapy and immunotherapy in advanced SCC J. Becker (Germany): C-Kit inhibitors for acral melanoma |
Dermoscopy Course II Chairs: H. Kittler (Austria) - G. Chaidemenos (Greece) In collaboration with the International Society of Dermoscopy H. Kittler (Austria): Clues for diagnosing non - and hypo- pigmented malignant skin tumors
E. Lazaridou (Greece): Facial pigmented lesions R. Cosgarea (Romania): Acral pigmented lesions A. Katoulis (Greece): Spitzoid lesions S. Puig (Spain): Dermoscopy and molecular biology |
Workshop 1 Prevention and Skin Cancer Screening Chairs: A. Geller (USA) – A.M. Forsea (Romania) – D. Polydorou (Greece) C. Garbe (Germany): Does primary prevention of skin cancer work anywhere in the world?
A.M. Forsea (Romania): Current standards in skin cancer screening P. Mohr (Germany): Lessons from the German skin cancer screening program Α. Sober (USA): Skin cancer screening in the United States V. del Marmol (Belgium): Screening and prevention of melanoma in Europe: Challenges and successes A. Geller (USA): Melanoma and skin cancer screening: What is the future? |
| 17:30-18:00 | Industry Satellite Lecture 2 Click here for more information |
Industry Satellite Lecture 3 Click here for more information |
|
| 18:15-18:30 |
Opening Ceremony Chairs: A. Stratigos (Greece) - C. Garbe (Germany) |
||
| 18:30-19:00 | Opening Keynote Lecture B. Bastian (USA): The Evolution from Melanocytes to Melanoma |
||
| 19:00 | Welcome Reception | ||
Thursday, May 4, 2017
| Time | Banquet Hall | N. Skalkotas Hall | MC2 |
| 08:00-09:30 | Symposium 3 Epidemiology of melanoma Chairs: V. del Marmol (Belgium) – S. Gandini (Italy) - E. Evangelou (Greece) E. Nagore (Spain): Epidemiologic trends of melanoma 1950-2017
V. del Marmol (Belgium): Novel risk associations of melanoma J.J. Grob (France): Fast growing melanomas: Do they exist? S. Gandini (Italy): Vitamin D and melanoma – An open controversy? D. Whiteman (Australia): The pathways to cutaneous melanoma |
Symposium 4
Actinic Keratoses / Field Cancerisation Chairs: T. Dirschka (Germany) - D. Ioannides (Greece) M. Trakatelli (Belgium): Epidemiology and biology of actinic keratoses T. Dirschka (Germany): Do we need a new classification of actinic keratoses? C. Longo (Italy): Imaging of AK and field cancerisation G. Gupta (United Kingdom): Topical therapy for actinic keratoses: An update E. Sotiriou (Greece): PDT for actinic keratoses: Daylight versus conventional? |
|
| 09:30-10:00 | Coffee Break - ePosters Viewing |
||
| 10:00-11:30 |
Symposium 5
Genetics of melanoma Chairs: J. Newton-Bishop (United Kingdom) – N. Hayward (Australia) – I. Stefanaki (Greece) N. Hayward (Australia): Novel high risk genes of melanoma E. Soura (Greece): Genetic markers of prognostic outcome S. Puig (Spain): Genetic testing in daily clinical practice J. Newton-Bishop (United Kingdom): Using primary tumor transcriptomics to understand melanoma progression A. Viros (United Kingdom): Update on melanoma and UV-carcinogenesis |
Symposium 6
Diagnostic Aspects / Pathology of Melanoma Chairs: B. Bastian (USA) – R. Scolyer (Australia) – I. Lefaki (Greece) B. Bastian (USA): Molecular classification of melanoma R. Scolyer (Australia): Is pahtology the gold standard for diagnosing melanocytic tumours: Does it always glitter? S. Ribero (Italy): Regression in melanoma: From diagnosis to prognosis K. Frangia-Tsivou (Greece):Tumour infiltrating cells in melanoma S. Murray (Greece): Molecular testing in melanoma – When, how and which test? |
|
| 11:30-12:30 | Plenary Lectures 1 Chairs: H. Pehamberger (Austria) – A. Hauschild (Germany) – E. Nicolaidou (Greece) D.E. Fisher (USA): Pathways of melanoma development: Prevention and therapeutic implications
D. Whiteman (Australia): The epidemiology of melanoma: Recent changes and future challenges J. Malvehy (Spain): New imaging approaches for the diagnosis of melanoma and skin cancer |
|
|
| 12:45-13:45 | Industry Satellite Lunch Sumposium 2 Click here for more information |
Lunch Break |
|
| 14:00-15:30 | Symposium 7 Surgery of Melanoma Chairs: V. Sondak (USA) - R. Kaufmann (Germany) - G. Champsas (Greece) R. Kaufmann (Germany): Current standards of surgical management in primary melanoma
A. Testori (Italy): Evidence-based assessment of SLN in primary melanoma V. Sondak (USA): Lymph node surgery in patients with advanced disease V. Sondak (USA): Surgery of distant metastatic disease J. Gershenwald (USA): SLN beyond melanoma: Clinical application in skin cancers other than melanoma |
Symposium 8
Melanocytic Nevi Chairs: V. Bataille (United Kingdom) – H. Kittler (Austria) – S. Georgiou (Greece)
V. Bataille (United Kingdom): Genetics of melanocytic nevi
H. Kittler (Austria): Classification of melanocytic nevi
V. Kinsler (United Kingdom): An update on CMM management
I. Zalaudek (Austria): Dysplastic nevus I. Stefanaki (Greece): Nevi monitoring: what’s new? |
Free Communications 1 Non-melanoma skin cancer: Merkel cell carcinoma, CTCL, rare skin tumours Chairs: A.M Forsea (Romania) - R. Vieira (Portugal) Click here for details |
| 15:30-16:30 | Industry Satellite Symposium 3 Click here for more information |
||
| 16:30-17:00 | Coffee Break & ePosters viewing |
||
| 17:00-18:30 |
Symposium 9
Adjuvant Therapy in Melanoma Chairs: A. Eggermont (France) - H. Gogas (Greece) H. Gogas (Greece): Updates in adjuvant melanoma trials A. Eggermont (France): Ipilimumab as an adjuvant approach to high risk melanoma B. Dreno (France): Anti- PD1 antibodies in the adjuvant setting A. Hauschild (Germany): Kinase inhibitors in the adjuvant setting H. Gogas (Greece): 2017 state of the art for adjuvant therapy in melanoma: Concluding remarks |
Symposium 10
Melanoma in Difficult Situations Chairs: P. Arenberger (Czech Republic) – L. Kandolf-Sekulovic (Serbia) – D. Rigopoulos (Greece) Z. Apalla (Greece): Melanoma and pregnancy C. Stefanaki (Greece): Melanoma arising in childhood P. Arenberger (Czech Republic): Current need of early diagnosis in metastatic melanoma D. Rigopoulos (Greece): Melanoma of the nail unit C. Harwood (United Kingdom): Melanoma in the immunosuppressed patient |
Free Communications 2 Topics in Dermato-oncology | Late breaking abstracts Chairs: R. Dummer (Switzerland) – E. Nagore (Spain) Click here for details |
| 18:30-19:30 | Special Session: Innovative Pathways for Innovative Treatments in Metastatic Melanoma Moderators: C. Garbe (Germany) - A.-M. Forsea (Romania) - L. Kandolf-Sekulovic (Serbia)
L. Kandolf-Sekulovic (Serbia): Access to innovative medicines in Europe: an overview
R. Giuliani (Italy): ESMO EU Policy Committee initiatives for improved access to innovative medicines B. Ryll (Sweden): Melanoma Patient Network Europe initiatives for improved access to innovative medicines A. Roediger (Switzerland): EFPIA initiatives for improved access to innovative medicines Panel discussion (all speakers) |
Industry Satellite Symposium 4 Click here for more information |
|
Friday, May 5, 2017
| Time | Banquet Hall | N. Skalkotas Hall | MC2 |
| 08:00-09:30 |
Symposium 11
Treatment Approaches for Advanced Stage BCC and SCC Chairs: A. Stratigos (Greece) - N. Basset-Séguin (France) – A. Katsambas (Greece) A. Stratigos (Greece): Update on systemic treatment of BCC N. Basset-Séguin (France): HPI resistance mechanisms and how to overcome it C. Dessinioti (Greece): Managing adverse reactions to HPI D. Schadendorf (Germany): Checkpoint blockade in NMSC R. Kunstfeld (Austria): Systemic treatment of BCC: Beyond hedgehog pathway inhibitors |
Symposium 12
Cutaneous Adverse Reactions to Chemotherapy and Targeted Therapies Chairs: C. Lebbe (France) - A. Katsarou (Greece) - P. Stavropoulos (Greece) A. Patsatsi (Greece): Classic cutaneous adverse reactions from chemotherapeutic agents C. Lebbe (France): Cutaneous reactions to anti-EGFR agents V. Sibaud (France): Cutaneous reactions to immune checkpoint inhibitors E. Livingstone (Germany): Cutaneous reactions to BRAF/MEK inhibitors and PI3K inhibitors I. Panoutsopoulou (Greece): A therapeutic algorithm for managing adverse skin reactions to targeted oncologic therapies |
Free Communications 3 Non-melanoma skin cancer: Basal cell and squamous cell carcinoma Chairs: P. Arenberger (Czech Republic) – J. Paoli (Sweden) Click here for details |
| 09:30-10:00 | Coffee Break & ePosters Viewing |
||
| 10:00-11:30 |
Symposium 13
Targeted Therapy of Advanced Melanoma Chairs: A. Hauschild (Germany) - G. Long (Australia) - D. Bafaloukos (Greece) D. Schadendorf (Germany): Clinical update on approved targeted therapies in advanced melanoma
C. Hoeller (Austria): Monitoring response to targeted therapies in advanced melanoma C. Robert (France): Resistance mechanisms to kinase inhibitors R. Dummer (Switzerland): New candidate therapeutic targets H. Linardou (Greece): Managing adverse reactions to kinase inhibitors |
Symposium 14
Regional Drug Therapies in Melanoma and NMSC Chairs: O. Zoras (Greece) - A. Testori (Italy) - N. Koliarakis (Greece) S. Agarwala (USA): Intralesional T-VEC and combination A. Testori (Italy): Electrochemotherapy O. Zoras (Greece): Isolated limb perfusion: Is it still an option? N. Rompoti (Greece): Lesional chemotherapy and cytokines G. Gaitanis (Greece): Immunocrysurgery |
Symposium 15
Melanoma Genetics and Biology Chairs: M.-T. Landi (USA) – S. Beissert (Germany) – T. Floros (Greece) M.-T. Landi (USA): Polygenic risk score for cutaneous melanoma in Mediterranean countries S. Beissert (Germany): UV-induced immunosuppression and melanoma development TBA: Novel pathways of resistance to targeted therapies S. Karagiannis (United Kingdom): B-cells and antibody responses in melanoma: immune escape mechanisms and opportunities for translation Th. Floros (Greece): Resistance to checkpoint inhibitors |
| 11:30-12:30 | Plenary Lectures 2 Chairs: H. Gogas (Greece) – A. Stratigos (Greece) J. Gershenwald (USA): The new (8th edition) AJCC melanoma staging system
G. Long (Australia): The evolving therapeutic landscape of advanced melanoma P. Nghiem (USA): Merkel cell carcinoma: New insights in biology and treatment |
|
|
| 12:45-13:45 | Industry Satellite Lunch Symposium 5 Click here for more information |
Lunch Break | |
| 14:00-15:30 |
Symposium 16
Immunotherapy of Advanced Melanoma: Beyond CTLA4 and PD-1 Chairs: D. Schadendorf (Germany) - R. Dummer (Switzerland) – A. Bamias (Greece)
C. Blank (The Netherlands): Update in anti-CTLA1 and anti-PD1 treatment in advanced melanoma
D. Bafaloukos (Greece): Open questions in immunotherapyC. Robert (France): Overcoming lack of response to checkpoint inhibitors R. Gutzmer (Germany): Οptimising use of antigen-specific immunotherapy in advanced melanoma S. Agarwala (USA): Targeted therapy and immunotherapy in uveal melanoma |
Symposium 17
Predictive Biomarkers and Disease Monitoring in Melanoma Chairs: H. Gogas (Greece) - J. Becker (Germany) O. Michielin (Switzerland): How does our surveillance algorithm change with the new therapies? P. Saiag (France): Serologic markers with predictive value J. Becker (Germany): Blood and tissue biomarkers of response to targeted therapy/immunotherapy E. Lianidou (Greece): Circulating tumour cells in melanoma S. Chatziioannou (Greece): Update on imaging for disease monitoring |
Free Communication 4 Melanoma Chairs: C. Hoeller (Austria) – H. Linardou (Greece) Click here for details |
| 15:30-16:30 |
|
|
Industry Satellite Symposium 6 Click here for more information |
| 16:30-17:00 | Coffee Break & ePosters viewing |
||
| 17:00-18:30 |
Symposium 18
Combination Treatments and Treatment Algorithms in Metastatic Melanoma Chairs: C. Blank (The Netherlands) - C. Robert (France) C. Garbe (Germany): Molecular testing for targeted therapies O. Michielin (Switzerland): Combining checkpoint inhibitors P. Ascierto (Italy): Combining immune checkpoint and kinase inhibitors R. Dummer (Switzerland): Combination of systemic with intralesional therapies |
Symposium 19
Brain Metastases Chairs: F. Meier (Germany) – Ι. Athanasiadis (Greece) A. Laskarakis (Greece): Brain metastases: Epidemiology and predisposing factors F. Meier (Germany): Brain metastases: The targeted approach (kinase inhibitors, checkpoint inhibitors)
P. Mohr (Germany): Brain metastases: Is their role of conventional chemotherapy? J.J. Grob (France): Brain metastases: Gamma knife and new treatments |
Surgical Workshop 2:
Surgical Approach of Melanoma. Its Role from Stage I to IV Chairs: R. Kaufmann (Germany) - D. Moreno (Spain) – P. Panayotou (Greece) J. Paoli (Sweden): Primary melanoma surgery R. Kaufmann (Germany): Surgery of primary melanoma in difficult sites A. Testori (Italy): Sentinel lymph node biopsy D. Tsoutsos (Greece): Nodal surgery D. Moreno-Ramirez (Spain): Surgical treatment of in-transit and M1a disease |
Saturday, May 6, 2017
| Time | Banquet Hall | N. Skalkotas Hall | MC2 |
| 08:30-10:00 |
Symposium 20
Treatment Approaches for Early and Advanced BCC and SCC Chairs: Ι. Leigh (United Kingdom) – M. Bylaitė-Bučinskienė (Lithuania) – I. Bassukas (Greece) E.Stockfleth (Germany): Updates on the biology and treatment of actinic keratosis
I. Leigh (United Kingdom): What is new in the biology of SCC? J. Lear (United Kingdom): How to define high risk BCC and SCC? G. Hofbauer (Switzerland): Topical therapies of NMSC R.-M. Szeimies (Germany): Conventional and daylight PDT K. Peris (Italy): Hedgehog inhibitors in advanced BCC |
Symposium 21
Cutaneous Lymphomas: Epidemiology, Diagnosis and Classification Chairs M.H. Vermeer (The Netherlands) - R. Knobler (Austria) - D. Sotiriadis (Greece) P. Quaglino (Italy): Classification of cutaneous lymphomas: New aspects
J. Scarisbrick (United Kingdom): Prognostic factors in Mycosis fungoides M.H. Vermeer (The Netherlands): Diagnostic approach in CD30+ cutaneus lymphomas R. Willemze (The Netherlands): Folliculotropic mycosis fungoides: An update V. Nikolaou (Greece): CD8+ Lymphoid infiltrates |
|
| 10:00-10:30 | Coffee Break & ePosters viewing |
||
| 10:30-12:00 |
Symposium 22
Rare Malignant skin tumours Chairs: P. Saiag (France) – J. Olah (Hungary) – V. Chasapi (Greece) K. Krasagakis (Greece): Merkel cell carcinoma P. Saiag (France): Dermatofibrosarcoma protuberans J. Olah (Hungary): Cutaneous sarcomas A. Befon (Greece): Adnexal malignant tumours M. Bylaitė-Bučinskienė (Lithuania): Genodermatoses with predisposition to skin cancer |
Symposium 23
E. Papadavid (Greece): Treatment of early stage Mycosis fungoidesCutaneous lymphomas: Management and treatment Chairs: R. Stadler (Germany) - C. Antoniou (Greece) - L. Marinos (Greece) R. Stadler (Germany): Treatment of late stage ΜF R. Knobler (Austria): Extracorporeal photopheresis for cutaneous T-cell Lymphoma update 2017 M. Siakantari (Greece): Treatment of cutaneous B-cell lymphomas P. Ortiz-Romero (Spain): New treatment for mycosis fungoides |
|
| 12:00-12:20 | CLOSING KEYNOTE LECTURE Managing Melanoma in 2017: Challenges and Perspectives Chairs: A. Stratigos (Greece) - N. Stavrianeas (Greece) C. Garbe (Germany): Challenges for Dermato-Oncology |
||
| 12:20-12:30 | POSTER AWARDS CEREMONY |
||
| 12:30-13:45 |
Workshop 3
Dermoscopy: Interactive cases Chairs: A. Stratigos (Greece) - A. Lallas (Greece) Experts Panel: My one best case: H. Kittler (Austria), J. Malvehy (Spain), S. Puig (Spain), A. Lallas (Greece) Case presenters: Z. Apalla (Greece), G. Evangelou (Greece), D. Sgouros (Greece), D. Papakostas (Greece), F. Chatzinasiou (Greece) |
Symposium 24
Dermatologic Surgery In collaboration with the Hellenic Society of Dermatologic Surgery Chairs: D. Dasiou (Greece) - P. Saiag (France) - G. Avgerinou (Greece) R. Vieira (Portugal): An update on surgery and Mohs for NMSC D. Dasiou (Greece): Reconstructive Surgery of special areas A. Kalampokas (Greece): Making surgical complications less complicated T. Anthopoulos (Greece): Reconstructive surgery of NMSC P. Polyzois (Italy): Combined curettage excision and cryosurgery for treatment of epithelial cancers of the skin |
|
| 13:45 | Closing Ceremony | ||